Volume 2, Issue 3
UPCOMING
Deep 6 presenting at DIA: June 27th
Deep 6 AI CEO, Wout Brusselaers, will present “The High ROI of AI for Clinical Trials Recruitment” as part of the “Artificial Intelligence: Robots Taking Over Clinical Research” session at DIA on Wednesday, June 27th from 10:30am to 11:45am.
Wout will be talking about how AI can make clinical trials much more cost effective and faster. He will use case studies to demonstrate AI techniques which improve and speed up trial design, site selection, patient accrual and outcomes analyses. All of which leverage real-time, real-world data. He will show how AI produces significant ROI.
Please reach out to Wout if you are going to be in Boston and schedule some time to chat after the session.
Deep 6 Has Launched
Version 2 of Cohort Builder
A couple of weeks ago, we got in front of a principal investigator who is running the trial “Long-term safety of Tafamidis in subjects with Transthyretin Cardiomyopathy” (NCT02791230/ B3461045). We walked him through the Deep 6 AI platforms version 2 of the Cohort Builder and ran the trial protocol query against his patient database. His response was:
He immediately submitted an IRB to get access to these patient records and began recruiting them. If you are interested in getting a demo please contact .
Come listen to Deep 6 on the Practical Applications of AI in Cancer Panel
Our Co-Founder and CEO, Wout Brusselaers, will be on the panel for “Practical Applications of AI in Cancer” at MedCity News CONVERGE on July 11th from 8:30am to 9:15am.
Wout will be speaking on how machine learning and AI can transform healthcare, not just in niche applications in oncology but also in-patient recruitment, data analysis, drug discovery and care delivery.
If you’re in Philadelphia on the 11th let Wout know and schedule some time to chat after the session.
Meet Deep 6 AI at
NRG Oncology: July 12-14
If you’re you going to be attending the NRG Oncology July 2018 Semiannual Meeting, we'd love to connect. Click here and set up a time to chat with our CEO, Wout Brusselaers
TWEET ROUNDUP
Best tweet of #ClinicalTrialsDay
(We aren’t biased at all)
Honorable Mention from Juniper Research for Best Platform/Technology
PAST EVENTS
Not candy but still cool - MM&M Awards
While not the lifetime supply of M&M’s that he thought he was getting Deep 6 AI Vice President of Business Development, Eric Gildenhuys, still thoroughly enjoyed accepting the Top 40 Transformers of 2018 award from MM&M on behalf of our CEO, Wout Brusselaers. We wanted to reiterate our appreciation for the award and event.
MM&M, is a sixty-year leader in news, analysis, and trends in pharmaceutical and healthcare marketing, and honored our CEO, Wout, as one of their top 40 transformers of 2018.
Suggested Readings
Industry happenings
Yahoo Finance
AI to Save Healthcare Sector US$52 Billion in 2021
"Scott Gottlieb, MD, is bullish on the opportunities artificial intelligence could bring to EHRs, decision support and more."
datasciencecentral.com
The Rise of the Citizen Data Scientist
“The development of Big Data, artificial intelligence and predictive analytics has created extravagant expectations for enterprise productivity growth”
News-Medical.net
Researchers find novel ways to improve participation in clinical research
"Videos and creative uses of other visuals provide a novel way to obtain informed consent during clinical trials to improve participants' understanding and retention of trial information, according to a study by Nemours Children's Health System presented at the American Thoracic Society (ATS) Annual Conference."
SAGE Journals
Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development
"The pharmaceutical industry is facing unprecedented challenges as the cost of developing new drugs has reached unsustainable levels, fueled in large parts by a high attrition rate in clinical development."
Let's Connect!
Deep 6 events calendar
